Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.10
Ask: 8.56
Change: -0.20 (-2.41%)
Spread: 0.46 (5.679%)
Open: 8.30
High: 8.30
Low: 8.10
Prev. Close: 8.30
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Aug 2018 16:47

RNS Number : 1851Z
Oxford BioDynamics PLC
29 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

2138005Y1TK258O5U928

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

 

A decrease in percentage ownership of the issuer's shares as a result of an increase in the issuer's issued share capital

X

3. Details of person subject to the notification obligationiv

Name

Philippa Hoyer Millar

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

28 August 2018

6. Date on which issuer notified (DD/MM/YYYY):

29 August 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4,473,140

-

4.85%

92,201,306

Position of previous notification (if

applicable)

4,473,140

-

5.2%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BD5H8572

4,473,140

-

4.85%

-

SUBTOTAL 8. A

4,473,140

4.85%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Oxford, UK

Date of completion

28 August 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEASPNALKPEFF
Date   Source Headline
28th Apr 20212:24 pmRNSHolding(s) in Company
9th Apr 20217:00 amRNSNew UK facilities to support expanded strategy
31st Mar 20217:00 amRNSOBD signs agreement with Agilent Technologies
24th Mar 202112:46 pmRNSResult of AGM
23rd Mar 20217:00 amRNSUS launch of EpiSwitch® COVID-19 Severity Test
17th Mar 20219:53 amRNSResults published of biomarker discovery program
23rd Feb 20211:36 pmRNSPublication of 2020 Annual Report and AGM date
28th Jan 20217:00 amRNSFinal Results
12th Jan 20217:00 amRNSNotice of Results
30th Dec 20207:00 amRNSDirectorate Change
15th Dec 20207:00 amRNSOxford BioDynamics to expand strategic focus
14th Dec 20207:00 amRNSAppointment of Chairman
2nd Nov 20207:00 amRNSStrategic partnership with Boca Biolistics
28th Oct 20207:00 amRNSDisease severity program for COVID-19 advances
8th Jul 20207:00 amRNSPDMR Dealing / Grant of Share Options
30th Jun 20201:04 pmRNSPDMR Dealing
23rd Jun 20202:09 pmRNSPDMR Dealing
17th Jun 20207:00 amRNSPDMR Dealing
16th Jun 20207:00 amRNSInterim results for six months ended 31 March 2020
3rd Jun 20201:30 pmRNSBoard transition
21st May 20207:00 amRNSBusiness update and notice of interim results
15th May 202012:47 pmRNSPDMR Dealing
14th May 202012:39 pmRNSPDMR Dealing
1st May 20207:00 amRNSChange of Registered Office
30th Apr 20207:00 amRNSBiomarker platform COVID-19 update
22nd Apr 20201:12 pmRNSPDMR Dealing
20th Apr 202011:10 amRNSPDMR Dealing
17th Apr 202010:47 amRNSPDMR Dealing
16th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20203:10 pmRNSPDMR Dealing
14th Apr 202011:42 amRNSPDMR Dealing
8th Apr 20204:34 pmRNSPDMR Dealing
2nd Apr 202011:08 amRNSPDMR Dealing - Replacement
31st Mar 20207:00 amRNSPDMR Dealing / Grant of Share Options
23rd Mar 20203:21 pmRNSPDMR Dealing
20th Mar 20203:02 pmRNSPDMR Shareholding
20th Mar 20201:37 pmRNSResults of Annual General Meeting
20th Mar 20207:30 amRNSDirector Dealing
19th Mar 20207:00 amRNSDirector Dealing
18th Mar 20207:00 amRNSPDMR Dealing
16th Mar 20207:00 amRNSBoard restructure to support future growth
2nd Mar 20205:04 pmRNSPDMR Dealing
2nd Mar 20205:03 pmRNSCorrection - PDMR Dealing
2nd Mar 20205:02 pmRNSCorrection - PDMR Dealing
28th Feb 20202:08 pmRNSPDMR Dealing
26th Feb 202011:49 amRNSPDMR Dealing
20th Feb 20207:00 amRNSOBD to present at BioTech Pharma Summit
20th Feb 20207:00 amRNSOBD to present at BioTech Pharma Summit
13th Feb 20204:41 pmRNSSecond Price Monitoring Extn
13th Feb 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.